COVID-19 should change how hospitals reduce respiratory virus risk

Publicly released:
International
Photo by Viki Mohamad on Unsplash
Photo by Viki Mohamad on Unsplash

Healthcare facilities need to change the way they view and protect their staff and patients from virus transmission following COVID-19, according to a review of international infection control policies. US researchers say most policies are based on an understanding that most viruses are transmitted by droplets large enough to only travel a maximum of two metres in the air. They say up-to-date research now shows aerosol transmission is more common than previously thought, with smaller droplets that can travel further and bypass surgical masks. The researchers say this new knowledge should be used to change healthcare practices to better protect staff and patients from airborne viruses.

Media release

From: American College of Physicians

Review finds many infection control policies based on outdated understanding of respiratory virus transmission
Abstract: https://www.acpjournals.org/doi/10.7326/M21-2780
Editorial: https://www.acpjournals.org/doi/10.7326/M21-4026
URL goes live when the embargo lifts
A review of COVID-19 transmission prevention studies found that many health care facility infection control policies are based on outdated models of how respiratory viruses are transmitted. Based on current best understanding of transmission, infection prevention methods should be revised. A narrative review including potential policy revisions is published in Annals of Internal Medicine.

Traditional teaching suggests that most respiratory viruses are spread through droplets. These are larger particles that are heavy enough that they will rapidly fall to the ground within one to two meters of an infected person. Public health agencies have traditionally advised healthcare workers to wear surgical masks to protect themselves from droplet organisms. The one exception has been for patients undergoing so-called, “aerosol-generating procedures” in which case higher levels of respiratory protection, such as N95 respirators, are recommended.

Researchers from Harvard Medical School, Harvard Pilgrim Healthcare Institute, and the University of Maryland reviewed published studies looking at SARS-CoV-2 transmission and infection control policies. They found that the traditional model of how respiratory viruses are spread may be incorrect. Most studies now suggest that respiratory viruses are primarily transmitted by aerosols. These are smaller respiratory particles that can remain suspended in the air for long periods of time, can travel beyond 2 meters from the source patient and, most importantly, can bypass surgical masks. People routinely generate aerosols whenever they exhale, particularly when speaking loudly, breathing heavily, or coughing. Most so-called “aerosol generating procedures” by contrast do not meaningfully increase aerosol generation relative to talking and heavy breathing.

These insights suggest that researchers and public health specialists should reexamine recommended transmission prevention methods. The authors suggest a uniform set of respiratory precautions for all respiratory pathogens and high-risk interactions rather than differentiating between different kinds of viruses and procedures. The authors recommend the creation of graded, risk-based approaches to prevent transmission in healthcare facilities that take into consideration the amount of disease in the community, patient factors, and care factors that better predict transmission risk.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research American College of Physicians, Web page The URL will go live after the embargo ends
Editorial / Opinion American College of Physicians, Web page The URL will go live after the embargo ends
Journal/
conference:
Annals of Internal Medicine
Organisation/s: Harvard Medical School, USA
Funder: By grant 6U54CK000484-04-02 from the Centers for Disease Control and Prevention (Drs. Klompas, Rhee, and Baker); grants from the National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Surveillance (HHSN272201400008C), the Centers of Excellence for Influenza Research and Response (75N93021C00014), the Centers for Disease Control and Prevention (200-2020-09528), and the National Science Foundation (2034755) (Dr. Milton); and grant 6 U01CK000556-02-02 fromthe Centers for Disease Control and Prevention (Dr. Leekha).
Media Contact/s
Contact details are only visible to registered journalists.